» Articles » PMID: 25545486

VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR TRACTIONAL AND NONTRACTIONAL DIABETIC MACULAR EDEMA: Long-term Results of a Comparative Study

Overview
Journal Retina
Date 2014 Dec 30
PMID 25545486
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the long-term outcomes of vitreomacular surgery in eyes with nontractional diabetic macular edema (DME) with those from eyes with tractional DME.

Methods: Retrospective comparative study from 55 consecutive patients (73 eyes). Twenty eyes were operated on for tractional DME and 53 eyes for nontractional DME unresponsive to laser photocoagulation or triamcinolone intravitreal injections. The best-corrected visual acuity, the central macular thickness, and the surgical complications were analyzed.

Results: The mean follow-up duration was 5.3 ± 2.4 years for the group with traction and 4.4 ± 1.7 years for the group without traction (P = 0.13). At 3 years, the mean logarithm of the minimum angle of resolution best-corrected visual acuity had improved significantly from 0.78 to 0.58 for the group without traction and from 0.75 to 0.45 for the group with traction (P < 0.001). At the final visit, there was no significant difference between the 2 groups in regard to visual or central macular thickness improvement (P = 0.447 and P = 0.742, respectively). The incidence of surgical complications was not significant between the two groups. The preoperative best-corrected visual acuity was the only predictive factor for the final best-corrected visual acuity.

Conclusion: The results of vitrectomy were not different in terms of anatomical and visual outcomes and surgical complications between eyes without tractional DME and eyes with tractional DME.

Citing Articles

Intraoperative OCT-Guided Selective Epiretinal Membrane (ERM) Peeling Versus ERM and Internal Limiting Membrane Peeling for Tractional Macular Edema in Diabetic Eyes.

Pignatelli F, Niro A, Viggiano P, Boscia G, Addabbo G, Boscia F Diagnostics (Basel). 2024; 14(23).

PMID: 39682520 PMC: 11640235. DOI: 10.3390/diagnostics14232610.


Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial.

Guo H, Li W, Nie Z, Zhang X, Jiao M, Bai S Trials. 2023; 24(1):685.

PMID: 37875997 PMC: 10594908. DOI: 10.1186/s13063-023-07735-w.


Diabetic retinopathy: emerging concepts of current and potential therapy.

Sadikan M, Abdul Nasir N Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3395-3406.

PMID: 37401966 DOI: 10.1007/s00210-023-02599-y.


Mid-term safety and effectiveness of macular peeling one month after intravitreal dexamethasone implant for tractional diabetic macular edema.

Pignatelli F, Niro A, Fallico M, Passidomo F, Gigliola S, Nacucchi A Sci Rep. 2023; 13(1):5990.

PMID: 37045880 PMC: 10097727. DOI: 10.1038/s41598-023-32780-5.


Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.

Ranno S, Vujosevic S, Mambretti M, Metrangolo C, Alkabes M, Rabbiolo G J Clin Med. 2023; 12(6).

PMID: 36983298 PMC: 10056256. DOI: 10.3390/jcm12062297.